TCG Lifesciences, the Rs 400-crore clinical research organisation (CRO) venture of the Chatterjee Group, has entered into an exclusive collaboration with the US-based pharma giant, Pfizer, to develop a portfolio of pre-clinical molecules for discovery of new drugs.

Japanese pharma major Eisai Co, said its Visakhapatnam facility will emerge as the global hub for R&D, formulations and active pharmaceutical ingredients (API) manufacturing in the years to follow.

Pharma major Dr Reddy's Laboratories (DRL) is gearing up for taking its new anti-cholesterol drug to Phase II trials.

GE Healthcare announced the launch of FTA DMPK cards for the collection and storage of blood samples for use in pharmacokinetic and toxicokinetic (PK/TK) studies.